A flat, color-blocked readout of the NAD+ literature — what the precursor trials actually measured, where oral NAD+ stops being absorbed, and why most products on the label are NMN or NR rather than NAD+ itself.
NAD Medicinal

SECTION 09 / GET IN TOUCH

Contact the NAD+ digest

Corrections, source suggestions, and editorial questions.

Read the researchAbout this digest

Reach the editors

NAD Medicinal is an editorial NAD+ research digest. Use the form below for corrections, citation suggestions, or questions about how a study is summarized. If you have spotted a figure that does not match its source, tell us which page and which number and we will check it against the primary literature.

We cannot and do not give medical advice, recommend doses, or answer personal health questions. We do not sell, compound, prescribe, or ship any product, and we have no clinic, pharmacy, or storefront. For medical questions, consult a qualified healthcare professional.

What this form is for

Good uses: pointing out a broken or misattributed citation, suggesting a peer-reviewed study we should add, flagging an unclear explanation, or asking about our sourcing. Not a fit: requests to buy NAD+, NMN, or NR; requests for an infusion or injection; requests for a dosing plan or a prescription. This is a reading resource about published NAD+ research, not a vendor and not a provider.